Healthcare
LifeStance Health Group, Inc.(LFST)
Live Price
Offline$9.05
+0.72% today
1Y Change
+81.41%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $2.94B
- Revenue Growth
- +13.9%
- EPS Growth
- +120.0%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
LifeStance Health Group, Inc. (LFST) is a Healthcare stock with a market cap of $2.94B and listed on NASDAQ. The stock last traded around $9.04 and up 81.4% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +13.9%, EPS growth of +120.0%, a dividend yield of 0.0%. What stands out right now is revenue +13.9%, EPS +120.0%, free cash flow +28.4% with operating margin 1.7% and ROIC 1.0%. Valuation already assumes a fairly strong business story at P/E 301.0 and price/sales 2.1. Stock Foundry combines LFST price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+13.9% vs +7.6% peer median
Operating Margin
Below sector median
+1.7% vs +19.4% peer median
P/E
Above sector median
301.0 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +13.9% and EPS at +120.0%, with operating margin around 1.7%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +3.3% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | +20.2% | +10.1% | +3.8% |
2026 Feb 25, 2026 | +3291.5% | -6.1% | -1.1% | -10.3% |
2025 Nov 6, 2025 | +127.7% | +0.6% | +1.0% | +3.7% |
Benchmark Edge
LFST vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
LFST
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
LFST Max Drawdown
-26.69%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for LFST and SPY.
Company Overview
LifeStance Health Group, Inc.
NASDAQ Global Select
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
- Leadership
- David Patrick Bourdon
- IPO Date
- Jun 10, 2021
- Employees
- 7.5k
- Street Address
- 4800 N. Scottsdale Road
- Mailing
- Scottsdale, AZ, 85251
- Region
- Scottsdale, AZ, US
- Reporting Currency
- USD
- Investor Line
- 602 767 2100
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 301.0
- EV/EBITDA
- 36.6
- Price/Sales
- 2.1
- Price/Book
- 1.9
Growth
- Revenue
- +13.9%
- EPS
- +120.0%
- Free Cash Flow
- +28.4%
Profitability
- Gross Margin
- 30.4%
- Operating Margin
- 1.7%
- Net Margin
- 0.7%
- ROE
- 0.7%
- ROIC
- 1.0%
Balance Sheet
- Debt/Equity
- 0.13
- Current Ratio
- 1.65
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.